Literature DB >> 16012051

Eph-modulated cell morphology, adhesion and motility in carcinogenesis.

Sabine H Wimmer-Kleikamp1, Martin Lackmann.   

Abstract

Eph receptor tyrosine kinases (Ephs) and their membrane anchored ephrin ligands (ephrins) form an essential cell-cell communication system that directs the positioning, adhesion and migration of cells and cell layers during development. While less prominent in normal adult tissues, there is evidence that up-regulated expression and de-regulated function of Ephs and ephrins in a large variety of human cancers may promote a more aggressive and metastatic tumour phenotype. However, in contrast to other RTKs, Ephs do not act as classical proto-oncogenes and do not effect cell proliferation or differentiation. Mounting evidence suggests that Eph receptors, through de-regulated re-emergence of their mode of action in the embryo may direct cell movements and positioning during metastasis, invasion and tumour angiogenesis. This review discusses these and other emerging roles of Eph receptors during oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012051     DOI: 10.1080/15216540500138337

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  24 in total

1.  The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.

Authors:  Roy Barco; Laura B Hunt; Andrea L Frump; Christina B Garcia; Andrew Benesh; Robert L Caldwell; Josiane E Eid
Journal:  Mol Biol Cell       Date:  2007-08-08       Impact factor: 4.138

2.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

3.  EphrinB reverse signaling in cell-cell adhesion: is it just par for the course?

Authors:  Hyun-Shik Lee; Ira O Daar
Journal:  Cell Adh Migr       Date:  2009-07-17       Impact factor: 3.405

4.  Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor.

Authors:  Carla M Lema Tomé; Enzo Palma; Sara Ferluga; W Todd Lowther; Roy Hantgan; Jill Wykosky; Waldemar Debinski
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

Review 5.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

6.  EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer.

Authors:  Jing-Jing Li; Zhi-Jian Sun; Yan-Mei Yuan; Fen-Fen Yin; Yao-Gang Bian; Ling-Yun Long; Xue-Li Zhang; Dong Xie
Journal:  J Biol Chem       Date:  2016-12-16       Impact factor: 5.157

7.  Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress.

Authors:  Jaime D Blais; Christina L Addison; Robert Edge; Theresa Falls; Huijun Zhao; Kishore Wary; Costas Koumenis; Heather P Harding; David Ron; Martin Holcik; John C Bell
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

8.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

9.  Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

Authors:  Birgit Mosch; Bettina Reissenweber; Christin Neuber; Jens Pietzsch
Journal:  J Oncol       Date:  2010-03-10       Impact factor: 4.375

10.  EphrinB1 controls cell-cell junctions through the Par polarity complex.

Authors:  Hyun-Shik Lee; Tagvor G Nishanian; Kathleen Mood; Yong-Sik Bong; Ira O Daar
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.